1.
comparative study between gliclazide, glibenclamide and glipizide on plasma glucose, C-peptide, lipid profile and on some peroxidative changes in diabetic rats
New Egyptian Journal of Medicine [The]. 1999; 21 (Supp. 4): 41-50
in English
| IMEMR
| ID: emr-52051
ABSTRACT
This study was performed on 50 male adult albino rats [10 normal and 40 alloxan-induced diabetic rats] divided into five groups, each of ten rats. The study recommended the use of gliclazide in NIDDM due to its excellent glycemic control and prevention of the long- term vascular complications; it also restores the abnormalities in lipid peroxides, oxidative markers and antioxidant enzymes